Agios Reports Second Quarter 2015 Financial Results and Provides Updates on Clinical Development Progress

Go back to Agios Reports Second Quarter 2015 Financial Results and Provides Updates on Clinical Development Progress
AGIOS PHARM (NASDAQ: AGIO) Delayed: 33.07 --0 (-0%)
Previous Close $33.07    52 Week High $71.49 
Open $33.07    52 Week Low $33.50 
Day High $33.07    P/E N/A 
Day Low $33.07    EPS $-1.18 
Volume 20